defective SARS-CoV-2 replication derived RNA vaccine (Centro Nacional Biotecnologia)

N/A

Report date: 2025/01/26 18:47:08

Base Information

Drug Namedefective SARS-CoV-2 replication derived RNA vaccine (Centro Nacional Biotecnologia)
Drug Alias NameRNA vaccine (Centro Nacional Biotecnologia)replication-defective SARS-CoV-2 vaccine (Centro Nacional de Biotecnología)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentro Nacional de Biotecnología
China Registration ClassN/A

Develop Information

Active CompaniesCentro Nacional de Biotecnología
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A